Pepper, C <br/><br/>
Pleiotropic drug resistance in B-cell chronic lymphocytic leukaemia--the role of Bcl-2 family dysregulation.  [electronic resource] 

 -  Leukemia research  Nov 1999 
 - 1007-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0145-2126 
<br/><br/><label>Standard No.: </label>10.1016/s0145-2126(99)00122-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Chlorambucil--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Neoplasm--genetics<br/>Etoposide--administration & dosage<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Vidarabine--administration & dosage